What is missing then and what will be the keystone to achieve these goals? The answer may seem trivial, but it is not: the radiologist's collaboration.
In fact, it will never be sufficient to collect only the data, raw or in DICOM format, also re-elaborated to constitute the so-called big data, but it will be necessary to correlate them with the radiological reports, so that the computer can process them and find the correlation between them and the "phenotype" in question.
But, to do this, the computer must have a "standardized" report, which, in part, is also referred to as a "structured report". It is therefore essential to elaborate and share a "format" of our reports, unique and common to all of us, and specific to each individual pathology. It is a huge effort, both for their drafting and for the uniform use in daily practice. A large scientific society is the only entity able today to achieve this goal. It, thanks to the large number of members, knows the peculiarities and skills of every radiologist to ask for the drafting of the structured report. It, thanks to the recognized authoritativeness, has the possibility to convey its use in a large number of structures.
Oncology is the first area in which to apply. Combining the huge amount of data "tagged" with the radiological reports will be like inserting the plug into the socket: our radiological world will glow with a new light. Our report will contain over time not only a subjective and qualitative interpretation of the images, our diagnosis, but also a series of numerical values, objective and quantitative features, our contribution to the prognosis, because some of them will have proved useful to predict the efficacy of the therapeutic response. And so the radiologist will formulate not only a diagnosis, but will also directly influence the therapeutic choice [2] .
Radiomics will be born. A further evolution, not so distant, will be possible when the patient will no longer be identified with his tax code, like today, but through biometric data such as his genome. When the genetic mapping becomes more economical and widespread, it will be finally possible to correlate the big data and the structured report, i.e. the phenotype, with the genotype.
